Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer
Clinical trial NCT00123929 · COMPLETED
Trial details
- NCT number
- NCT00123929
- Sponsor
- Hospital San Carlos, Madrid
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2009-05-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.